IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222900. A total of 4 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,070 | +16.9% | 85,400 | +6.4% | 0.00% | +50.0% |
Q1 2024 | $3,481 | +322.5% | 80,300 | +392.6% | 0.00% | +100.0% |
Q4 2023 | $824 | -56.5% | 16,300 | -61.0% | 0.00% | 0.0% |
Q3 2023 | $1,896 | +204.3% | 41,800 | +175.0% | 0.00% | 0.0% |
Q2 2023 | $623 | -65.5% | 15,200 | -69.9% | 0.00% | -50.0% |
Q1 2023 | $1,804 | +27.0% | 50,500 | +34.3% | 0.00% | 0.0% |
Q4 2022 | $1,420 | -99.9% | 37,600 | -12.1% | 0.00% | 0.0% |
Q3 2022 | $1,893,000 | +109.6% | 42,800 | +75.4% | 0.00% | +100.0% |
Q2 2022 | $903,000 | +46.1% | 24,400 | +46.1% | 0.00% | 0.0% |
Q1 2022 | $618,000 | -16.0% | 16,700 | -31.0% | 0.00% | 0.0% |
Q4 2021 | $736,000 | -72.2% | 24,200 | -63.4% | 0.00% | -50.0% |
Q3 2021 | $2,647,000 | +0.9% | 66,100 | +0.5% | 0.00% | -33.3% |
Q2 2021 | $2,624,000 | -48.3% | 65,800 | +5723.0% | 0.00% | -66.7% |
Q1 2021 | $5,080,000 | -12.6% | 1,130 | +9.9% | 0.01% | +12.5% |
Q4 2020 | $5,812,000 | +192.4% | 1,028 | +145.3% | 0.01% | +166.7% |
Q3 2020 | $1,988,000 | +29.8% | 419 | +61.2% | 0.00% | +50.0% |
Q2 2020 | $1,532,000 | +24.1% | 260 | -0.4% | 0.00% | 0.0% |
Q1 2020 | $1,234,000 | -59.1% | 261 | -47.7% | 0.00% | -71.4% |
Q4 2019 | $3,014,000 | +51.1% | 499 | +49.8% | 0.01% | +16.7% |
Q3 2019 | $1,995,000 | +11.7% | 333 | +19.8% | 0.01% | +20.0% |
Q2 2019 | $1,786,000 | -7.9% | 278 | +16.3% | 0.01% | 0.0% |
Q1 2019 | $1,939,000 | +118.8% | 239 | +45.7% | 0.01% | +66.7% |
Q4 2018 | $886,000 | -58.3% | 164 | -60.2% | 0.00% | -57.1% |
Q3 2018 | $2,125,000 | +168.6% | 412 | +116.8% | 0.01% | +133.3% |
Q2 2018 | $791,000 | +2536.7% | 190 | +37.7% | 0.00% | +200.0% |
Q1 2018 | $30,000 | -66.3% | 138 | -63.9% | 0.00% | -75.0% |
Q4 2017 | $89,000 | -60.8% | 382 | -12.0% | 0.00% | -55.6% |
Q3 2017 | $227,000 | +11.3% | 434 | -6.3% | 0.01% | 0.0% |
Q2 2017 | $204,000 | +119.4% | 463 | -40.9% | 0.01% | +125.0% |
Q1 2017 | $93,000 | -74.9% | 784 | +22.5% | 0.00% | -81.8% |
Q4 2016 | $370,000 | +160.6% | 640 | +58.8% | 0.02% | +120.0% |
Q3 2016 | $142,000 | +255.0% | 403 | -35.6% | 0.01% | +233.3% |
Q2 2016 | $40,000 | -58.8% | 626 | +80.4% | 0.00% | -62.5% |
Q1 2016 | $97,000 | -83.4% | 347 | -2.5% | 0.01% | -82.6% |
Q4 2015 | $583,000 | – | 356 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Partner Investment Management, L.P. | 8,000 | $293,000 | 0.43% |
PFM Health Sciences, LP | 349,800 | $12,817,000 | 0.38% |
SABBY MANAGEMENT, LLC | 2,171 | $7,955,000 | 0.30% |
GROUP ONE TRADING, L.P. | 197,000 | $7,218,000 | 0.08% |
SIMPLEX TRADING, LLC | 403 | $142,000 | 0.01% |
Timber Hill LLC | 51,900 | $1,902,000 | 0.01% |